|
GPATCH8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.387800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.363200E-01 |
| Normal-vs-Stage2 |
8.320200E-01 |
| Normal-vs-Stage3 |
1.101580E-01 |
| Normal-vs-Stage4 |
4.001700E-02 |
| Stage1-vs-Stage2 |
5.248600E-01 |
| Stage1-vs-Stage3 |
2.479600E-03 |
| Stage1-vs-Stage4 |
4.194300E-04 |
| Stage2-vs-Stage3 |
1.379960E-01 |
| Stage2-vs-Stage4 |
5.954300E-02 |
| Stage3-vs-Stage4 |
5.928000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.535600E-01 |
| Normal-vs-AfricanAmerican |
7.691200E-01 |
| Normal-vs-Asian |
8.402600E-03 |
| Caucasian-vs-AfricanAmerican |
8.861200E-01 |
| Caucasian-vs-Asian |
1.560110E-02 |
| AfricanAmerican-vs-Asian |
4.820200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.686600E-01 |
| Normal-vs-Female |
4.638600E-01 |
| Male-vs-Female |
7.507600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.812400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.180400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.535400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.341600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.504600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.409200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.173800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.152500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.725900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.637400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.13919999999534E-05 |
| Normal-vs-Grade 2 |
2.589800E-01 |
| Normal-vs-Grade 3 |
2.803600E-01 |
| Normal-vs-Grade 4 |
1.245620E-02 |
| Grade 1-vs-Grade 2 |
1.557280E-03 |
| Grade 1-vs-Grade 3 |
1.52542999999339E-05 |
| Grade 1-vs-Grade 4 |
2.85579999981245E-07 |
| Grade 2-vs-Grade 3 |
5.739200E-03 |
| Grade 2-vs-Grade 4 |
3.430400E-04 |
| Grade 3-vs-Grade 4 |
8.596300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.643900E-02 |
| Normal-vs-ccB subtype |
2.823200E-01 |
| ccA subtype-vs-ccB subtype |
4.800200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.440200E-01 |
| Normal-vs-N1 |
2.636600E-01 |
| N0-vs-N1 |
2.954400E-01 |
|
|
